SDF-1 binding nucleic acids and the use thereof in cancer treatment

Patent Number: 9387221

Patent Date: 2016-07-12

Patent type: utility

The present invention is related to a nucleic acid molecule capable of binding to SDF-1, preferably capable of inhibiting SDF-1, whereby the nucleic acid molecule is for use in a method for the treatment and/or prevention of a disease or disorder, for use in a method for the treatment of a subject suffering from a disease or disorder or being at risk of developing a disease or disorder as an adjunct therapy, or for use as a medicament for the treatment and/or prevention of a disease or disorder, whereby the disease or disorder is cancer.

Inventors

First Name Last Name City State Country
Sven Klussmann - - -
Dirk Eulberg - - -
Christian Maasch - - -
Florian Jarosch - - -
Werner Purschke - - -
Klaus Buchner - - -
Nicole Dinse - - -
Dirk Zboralski - - -

IPCs

Section Class Sub Class Group Sub Group
C 12 N 15 11
A 61 K 48 00
C 07 H 21 02
C 12 N 15 115
A 61 K 31 713
A 61 K 45 06

Assignee

Organization First Name Last Name City State Country
NOXXON Pharma AG - - - - -